SEMICONDUCTOR LASER INTERNATIONAL CORP
10QSB, 2000-05-15
SEMICONDUCTORS & RELATED DEVICES
Previous: PDS FINANCIAL CORP, 10-Q, 2000-05-15
Next: CV THERAPEUTICS INC, 10-Q, 2000-05-15




                                    UNITED STATES
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C.  20549


                                 --------------------

                                     FORM 10-QSB

(Mark one)
[x]    Quarterly Report under section 13 or 15(d) of the Securities
       Exchange Act of 1934

                       For the quarter ended March 31, 2000

[ ]    Transition Report under section 13 or 15(d) of the Securities
       Exchange Act of 1934

                       For the period from ______ to ______

                              Commission File No. 0-27908

                      Semiconductor Laser International Corporation
  ------------------------------------------------------------------------
       (Exact Name of Small Business Issuer as Specified in its Charter)

             Delaware                                      16-1494566
- ----------------------------------------              -------------------
(State or other Jurisdiction of                         (I.R.S. Employer
Incorporation or Organization)                         Identification No.)

                    15 Link Drive, Binghamton, New York 13904
                    -----------------------------------------
                    (Address of principal executive offices)

                                (607) 722-3800
                                --------------
                         (Issuer's telephone number)

- --------------------------------------------------------------------------------
(former name,former address and former fiscal year,if changed since last report)


     As of April 30, 2000, there were 28,478,263 shares of the issuers common
stock, par value $.01 per share outstanding.

Transitional Small Business Disclosure Format

               Yes    [ ]                        No    [x]

<PAGE>
                                       1

                         Part I. Financial Information

Item 1. Financial Statements


                   Semiconductor Laser International Corporation

                                   Balance Sheet
<TABLE>
<CAPTION>

                                                   December 31,      March 31,
                                                       1999            2000
                                                                    (unaudited)
                                                   ------------     ------------
<S>                                               <C>              <C>
Assets
Current assets
  Cash and cash equivalents                       $    347,747     $  4,999,660
  Accounts Receivable, net of allowance for
   doubtful accounts of $583,293 and $583,293,
   respectively                                        295,561          290,683
  Inventory                                            861,911          877,074
  Prepaid expenses and other assets                     24,957           24,957
                                                   ------------     ------------
                  Total current assets               1,530,176        6,192,374

Property, plant and equipment, net                   2,584,974        2,533,524
Deposits and other assets                              149,396          132,802
                                                   ------------     ------------
                  Total assets                    $  4,264,546     $  8,858,700
                                                   ============     ============

Liabilities and Shareholders' Equity
Current liabilities
  Accounts payable                                $    708,193     $    770,114
  Notes Payable ( Line of Credit )                   1,000,000        1,000,000
  Accrued expenses and other liabilities               174,809          193,797
  Current portion of long-term debt                     44,368           41,505
                                                   ------------     ------------
                  Total current liabilities          1,927,320        2,005,416

Long-term debt                                         713,668          703,122
Accrued royalty payments                               100,000          100,000
                                                   ------------     ------------
                  Total liabilities                  2,741,038        2,808,538
                                                   ------------     ------------
Commitments and contingencies (Notes 2 and 5)

Shareholders' Equity
Common stock, $.01 par value, 75,000,000 shares
 authorized, 15,641,064 issued and outstanding
 at December 31, 1999; 28,474,397 issued and
 outstanding at March 31, 2000                         156,411          284,744
Subscriptions Receivable                              (100,000)            -
Treasury stock                                        (248,241)        (248,241)
Convertible Preferred Stock                             10,000           10,000
Additional paid-in capital                          22,034,365       27,636,453
Accumulated deficit                                (20,329,027)     (21,632,794)
                                                   ------------     ------------
                  Total Shareholders' Equity         1,523,508        6,050,162
                                                   ------------     ------------
                  Total Liabilities and
                    Shareholders' Equity          $  4,264,546     $  8,858,700
                                                   ============     ============
</TABLE>

                  See accompanying notes to financial statements

<PAGE>
                                       2

                  Semiconductor Laser International Corporation

                             Statement of Operations

<TABLE>
<CAPTION>
                                                       Three Months Ended
                                                            March 31,
                                                      1999             2000
                                                   (unaudited)      (unaudited)
                                                   -----------      -----------
<S>                                                <C>              <C>
Net sales                                          $   298,545          405,850

Cost of sales                                         (663,886)        (813,766)
                                                   -----------      -----------
     Gross margin                                     (365,341)        (407,916)

Operating expenses:

Research and development expenses                  $     1,738      $    11,774
Sales and marketing expenses                            63,220           82,681
General and administrative expenses                    570,804          821,861
                                                    ----------       ----------
         Loss from operations                        1,001,103        1,324,232

Interest income                                            305           20,465
                                                    ----------       ----------
         Net loss                                    1,000,798        1,303,767
                                                    ==========       ==========

Earnings per share - basic and diluted                ($0.09)          ($0.07)
                                                    ==========       ==========

Weighted average shares outstanding                 11,226,052       18,125,138
                                                    ==========       ==========

</TABLE>



                  See accompanying notes to financial statements

<PAGE>
                                       3

                  Semiconductor Laser International Corporation

                            Statement of Cash Flows

<TABLE>
<CAPTION>
                                                       Three Months Ended
                                                            March 31,
                                                      1999            2000
                                                   (unaudited)     (unaudited)
                                                   -----------     -----------
<S>                                                <C>             <C>
Cash flows from operating activities:
Net loss                                           $(1,000,798)    $(1,303,767)
Adjustments to reconcile net loss to
  net cash used in operating
  activities:
   Depreciation and amortization                        51,990          51,870

Change in assets and liabilities:
   (Increase)/decrease in accounts
     receivable, net                                   144,745           4,878
   (Increase)/decrease in inventory                     10,390         (15,163)
   (Increase)/decrease in prepaid
     expenses and other assets                           4,731             -
   (Increase)/decrease in deposits
     and other assets                                  (27,160)         16,594
   Increase/(decrease) in accounts
     payable                                           (18,998)         61,921
   Increase/(decrease) in accrued
     expenses and other liabilities                      6,882          16,126
                                                   -----------     -----------
Net cash used in operating activities                 (828,218)     (1,167,541)
                                                   -----------     -----------
Cash flows from investing activities:
Purchase of property, plant and
   equipment                                              (326)         -
Sale of equipment                                           -           -
                                                   -----------     -----------
Net cash provided from (used for)
   investing activities                                   (326)         -
                                                   -----------     -----------
Cash flows from financing activities
Issuance of stock, net of expenses                     707,964       5,830,000
Issuance of warrants                                    31,500           -
Proceeds from short-term debt                          300,000           -
Payments on long-term debt                              (9,769)        (10,546)
                                                   -----------     -----------
Net cash provided by financing
   activities                                        1,029,695       5,819,454
                                                   -----------     -----------
Net increase in cash, cash
   equivalents and restricted cash                     201,151       4,651,913
Cash, cash equivalents and restricted
   cash at beginning of period                         112,695         347,747
                                                   -----------     -----------
Cash, cash equivalents and restricted
   cash at end of period                             $ 313,846     $ 4,999,660
                                                   ===========     ===========

</TABLE>


                  See accompanying notes to financial statements

<PAGE>
                                        4

                  Semiconductor Laser International Corporation


                          Notes to Financial Statements
                                  March 31, 2000
                                   (Unaudited)


1. Organization

   Semiconductor Laser International Corporation (the "Company") was
   incorporated in New York State in September 1993 and, subsequently,
   reincorporated in Delaware in September 1997, to produce high power
   semiconductor diode laser wafers and bars ("HPDLs"), and to market these
   products worldwide.

2. Financial Resources and Liquidity

   The Company has incurred net losses from inception and has at March 31, 2000
   an accumulated deficit of $21,632,373 and working capital of $4,186,958.
   While the Company has raised approximately $5.7 million from a series of
   private placements since January 1, 2000, ( See Note 8 ), certain of the
   monies will be utilized to pay payables in arrears.

   Prospectively, however, the Company needs to demonstrate an ability to
   increase its sales, generate positive gross margins and net income.  Based
   upon the fiscal 2000 budget, the Company expects that its cash and working
   capital requirements will continue to be significant as its operations
   expand.  The Company expects that such cash and working capital requirements
   will be satisfied through a combination of revenue growth and additional
   private equity financings.  There can be no assurance that such additional
   financing can be consumated.

<PAGE>
                                       5

3. Basis of Presentation

   The accompanying unaudited financial statements have been prepared by the
   Company.  Certain information and footnote disclosures normally included in
   financial statements prepared in conformity with generally accepted
   accounting principles have been condensed or omitted.  In the opinion of the
   Company's management, the disclosures made are adequate to make the
   information presented not misleading, and the financial statements contain
   all adjustments necessary to present fairly the financial position as of
   March 31, 2000 and the results of operations and cash flows for the three
   months ended March 31, 2000 and 1999.  The results of operations for the
   three months ended March 31, 2000 are not necessarily indicative of the
   results to be expected for the full year.

4. Summary of Significant Accounting Policies

   Use of estimates

   The preparation of financial statements in conformity with generally
   accepted accounting principles requires management to make estimates and
   assumptions that affect the reported amount of assets and liabilities and
   disclosure of contingent assets and liabilities as of the date of the
   financial statements and the reported amounts of revenue and expenses during
   the period.  Actual results could differ from those estimates.

   Cash and Cash Equivalents

   The Company considers all highly liquid investments with an original maturity
   of three months or less, at the date of purchase, to be cash equivalents.

   Inventory

   Inventory is valued at the lower of cost or market on a first in, first out
   (FIFO) method.

   Depreciation and amortization

   Property, plant and equipment are recorded at cost and depreciated over
   the assets' estimated useful lives ranging from three to twenty years.
   Depreciation is computed using the straight-line method for financial
   reporting.  Expenditures for major renewals and betterments that extend the
   useful lives of the property and equipment are capitalized.  Expenditures for
   maintenance and repairs are charged to expense as incurred.

   Impairment of long-lived assets

   Assessments of the recoverability of long-lived assets are conducted when
   events or circumstances occur that indicate that the carrying value of the
   asset may not be recoverable.  The measurement of impairment is based on the
   ability to recover such carrying value from the future undiscounted cash
   flows of related operations.  In the event such cash flows are not to be
   sufficient to recover the recorded value of the assets, the assets are
   written down to their estimated fair values.

<PAGE>
                                       6

   Revenue recognition

   Revenue recognition is based on the terms of the underlying sales agreements
   (purchase orders or contracts), typically when products are shipped to
   customers.

   Research and development

   Research and development costs are expensed as incurred.

   Income taxes

   The Company provides for income taxes in accordance with the liability method
   as set forth in Financial Accounting Standards No. 109, "Accounting for
   Income Taxes".  This method provides that deferred tax assets and liabilities
   are recorded, using currently enacted tax rates, based upon the difference
   between the tax bases of assets and liabilities and their carrying
   amounts for financial statement purposes.  A valuation allowance is
   recorded when it is more likely than not that deferred tax assets will
   not be realized.

   Net loss per share

   Net loss per share, basic and diluted,  is computed using the weighted
   average number of shares of common stock outstanding.

   As of March 31, 2000, the Company had outstanding warrants and options to
   purchase 12,423,271 and 562,629 shares of common stock, respectively, which
   are not included in the calculation of earnings per share for the three
   months ended March 31, 2000, and would not be included in such calculation
   due to the anti-dilutive nature of these instruments.  Of the warrants
   excluded from such calculation, 1,948,000 expired by their terms on March 19,
   2000.

   As of March 31, 1999, the Company had outstanding warrants and options to
   purchase 3,446,334 and 148,455 shares of common stock, respectively, which
   are not included in the calculation of earnings per share for the three
   months ended March 31, 1999, and would not be included in such calculation
   due to the anti-dilutive nature of these instruments.

<PAGE>
                                       7

5. Commitment, Contingencies and Other Matters

   Operating Leases

   Rent expense under non-cancellable operating leases, including the FINOVA
   leases, was $262,660 for the three months ended March 31,2000.  Rent expense
   under non-cancellable operating leases, including the FINOVA leases, was
   $278,860 for the three months ended March 31, 1999.

   Future minimum payments under non-cancellable operating leases, including
   the FINOVA lease agreement, at March 31, 2000, are as follows:

<TABLE>
<CAPTION>

                                 Year ending
                                 December 31,      Commitment
                                -------------     -------------
<S>                                 <C>            <C>
                                    2000(1)        $  755,061(1)
                                    2001              605,207
                                                  -------------
                                                   $1,360,268
                                                  =============
           (1) Nine months

</TABLE>

6. Income taxes

Net operating loss carry forwards of approximately $20,500,000 expire in
the years 2008 to 2013. Internal Revenue Code Section 382 places a
limitation on the utilization of Federal net operating loss carry forwards
when an ownership change, as defined by tax law, occurs.  The annual
utilization of net operating loss carryforward generated prior to such
changes in ownership will be limited, in any one year, to a percentage of
fair market value of the Company at the time of the ownership change.


7. Litigation/Investigation

The Company is currently engaged in litigation with a former employee, Dr.
Keith Evans, against whom the Company brought an action for breach of
confidentiality obligations and defamation of character.  In 1997, Dr. Evans
responded with a counter claim alleging defamation of character and is
seeking $500,000 in damages.  The action is pending in the Supreme Court of
Broome County, New York.  The litigation is presently in the discovery
stage.  The Company believes the counter claim is without merit and is
vigorously defending such action and further, believes that the ultimate
outcome of such action will not have a material impact on the financial
condition, results of operations or cash flows of the Company.

   Since April 1998, the Company had been responding to informal requests for
information from the Securities and Exchange Commission(the"Commission").  In
August 1998, the Company learned that in June 1998, the Commission had issued
a formal order of investigation to determine whether violations of certain
aspects of the federal securities laws had occurred in connection with the
Company. Pursuant to this formal order of investigation, the Company and
certain of its current and former officers and directors have produced
documents pursuant to subpoenas from the Northeast Regional Office of the
Commission.  The Company does not know whether or not this investigation
remains active and is not able to speculate as to the specific subject matter
of the investigation.  There can be no assurance as to the timeliness of the
completion of the investigation or as to the final result thereof, and no
assurance can be given that the final result of the investigation will not
have a material adverse effect on the Company.  The Company has cooperated
with the investigation and has responded to all requests for information in
connection with the investigation.  No such requests for information has been
forthcoming since late 1998.

    In August 1998, the Company learned that the United States Attorney's
Office for the Southern District of New York is investigating whether violations
of securities laws have occurred in connection with the Company's public
disclosures but has been informed that the Company is not presently a target
of the investigation.  The Company has cooperated fully with the
investigation and has responded to a grand jury subpoena issued in connection
with the investigation.  The Company does not know whether or not this
investigation remains active and is unable to speculate as to the outcome or
possible effect of the investigation on the Company or its management.  There
can be no assurance as to the timeliness of the completion of the
investigation or as to the final result thereof, and no assurance can be
given that the final result of the investigation will not have a material
adverse effect on the Company or its current management.  Management believes
that there are meritorious defenses to the issues raised by this
investigation and intends to defend this matter vigorously.  No requests for
information have been received since late 1998.

     In November 1999,  an action was filed against the Company and several of
its present and former officers and directors in the United States Federal Court
for the District of Massachusetts entitled Timothy Geran v. Semiconductor Laser
International Corporation,  Whale Securities Co., LP, Geoffrey T. Burnham, Allen
W. Johnson, Jr., Theodore W. Konopelski, Susan M. Burnham, George Barrett, David
L. Koffman, Brian Thompson, and Nicholas L. Prioletti, Jr., Case No. CA99-30-251
- -MAP.  The Complaint alleges violations by the defendants of Section 12(a)(2) of
the Securities Act of 1933 arising out of alleged misrepresentations by
defendants as to the Company  that  allegedly  induced  plaintiff  to purchase
warrants to purchase the Company's common stock.  The Complaint seeks damages of
$27,782.  The Company  believes  it has  meritorious  defenses  to this  action
and intends to defend the action vigorously and further,  believes that the
ultimate outcome of such action will not have a material impact on the financial
condition or results of  operations  of the Company.

The Company is currently engaged in litigation with Newport Corporation in the
Supreme Court of Broome County, New York, a vendor who is seeking to recover
$100,508 for goods allegedly sold to the Company.  The action was commenced on
June 2, 1999.  Based on losses sustained by the Company as a result of
previously supplied defective equipment from this vendor, the Company's
counterclaim exceeds the amount sued for by Newport Corporation.  The Company
believes that the ultimate outcome of the action will not have a material impact
on the financial condition or results of operations of the Company.

The Company is currently engaged in litigation with IOS Capital Corporation,
a vendor who is seeking to recover $55,821 on the basis of an alleged default
by the Company in making its lease agreement installments for color copying
equipment. The action was commenced on July 9, 1999 in the Supreme Court of
Oneida County, New York.  The Company believes that the vendor was incapable of
providing a working product acceptable to the Company and the equipment was
returned to the vendor as a result.  The Company believes that the ultimate
outcome of the action will not have a material impact on the financial condition
or results of operations of the Company.

The Company is currently engaged in a lawsuit with one of its customers, Rocky
Mountain Instruments ("RMI"). RMI disputes the amounts owed to the Company
regarding certain orders, has made claims regarding defects in certain of the
units delivered and it is currently late in making payments on such orders.  The
Company believes that RMI owes approximately $468,571(including a late charge)
to the Company.  The Company also has asserted claims for lost profits and
other damages.  The Company has retained an expert in the lawsuit with RMI to
determine the amount of its damages.  On November 2, 1999 the Company filed a
Complaint and Jury Demand against RMI in District Court claiming, among other
things, that RMI had breached its contract and failed to fulfill its promises
relating to RMI's purchase of laser diodes from the Company.  A trial date has
not yet been established.  The Company's allowance for doubtful accounts
includes the aforementioned amount which remains uncollected.


 <PAGE>
                                       8

8.  Financing

The Company entered into a Securities  Purchase  Agreement (the "Securities
Purchase Agreement"), dated as of February 5, 1999, with bmp Mobility AG Venture
Capital ("bmp"),  as amended by Amendment No. 1 to Securities Purchase Agreement
(the  "Amendment"),  dated  as  of  April  28,  1999  (the  Securities  Purchase
Agreement,  as  amended  by the  Amendment  is  hereinafter  referred  to as the
"Amended  Purchase  Agreement").  Pursuant to the terms of the Amended  Purchase
Agreement, bmp purchased, 2,000,000 shares of the Company's Common  Stock and
1,000,000  shares of the Company's Series B Convertible  Preferred Stock,$.01
par value per share, (the "Series B Stock") each  convertible  into 5 shares
of the  Company's  Common  Stock or an aggregate of 5,000,000 shares of the
Company's Common Stock.  bmp had  previously  purchased  367,650  shares  of the
Company's  Common Stock in  unrelated  open market  transactions.  In connection
with the Amendment, on June 26, 1999 the Company issued to bmp a five year
warrant to purchase an aggregate of 500,000 shares Common Stock, at an exercise
price of $0.50 per share (the "bmp Warrrant").

In  connection  with the  Amendment,  the Company  entered  into a consulting
agreement, dated as of April 28, 1999, (the "Consulting  Agreement") between the
Company and bmp Management Consultants GmbH ("bmp Consultants"), a German
limited  liability  corporation  wholly-owned by bmp AG  Venture  Capital  &
Network Management, the parent company of bmp, providing for the retention of
bmp Consultants as strategic and financial consultants to the Company, for an
aggregate  consulting fee of $200,000.  Pursuant to a verbal agreement with bmp
Consultants the Company will be billed on a work performed basis for the
$200,000 aggregate consulting fee.  As of March 31, 2000, bmp Consultants had
been paid $80,887.  bmp is no longer providing such services.  In addition, bmp
is eligible to receive a finder's fee in the amount of 5% of the net proceeds of
any transaction involving the raising of debt or equity capital in a private
placement from a source introduced to the Company by bmp consummated by the
Company until June 26, 2001.  The shares of Common Stock issued to bmp contain
certain demand and piggyback registration rights and the Series B Stock contains
certain anti-dilution rights.  Based on public filings, the Company is aware
that bmp has transferred ownership of its shares of Common Stock, Series B Stock
and the bmp Warrant to ANB Alster Neue Beiteiligungs GmbH KG ("ANB").

The Company has available a collateralized line of credit with BSB Bank(the
"Loan Agreement"), subject to a borrowing base calculation, with an aggregate
availability in the amount of $1,000,000 for purposes of providing working
capital. The line, bears interest at prime plus 2.5%. The Company has utilized
$1,000,000 of this line as of March 31, 2000.

In January 2000, BSB required the Company to provide it with additional security
for the Loan Agreement in the form of a $750,000 second mortgage on the
Company's facility and a first security interest in all of its assets.  The
second mortgage and the security agreement granting the requested security
interest were executed and delivered to BSB on January 31, 2000.  BSB has agreed
to release the lien of the second mortgage upon satisfaction of its first
mortgage, and a pay down or permanent reduction of the Company's line of credit
with BSB of $300,000 or a pledge of cash collateral in such amount.

BSB agreed to waive the default of the Company under the Loan Agreement with
respect to "Mandatory Loan Repayments" and waived the Affirmative Covenants -
"Financial Covenants and Ratios" at December 31, 1999. Subsequently, BSB agreed
to waive the default of the Company under the Loan Agreement with respect to
"Mandatory  Loan  Repayments" for the period ending February 29,
2000 provided the Company met the  borrowing  base  requirements  as of March 3,
2000. These requirements were met by the Company.  On May 8, 2000, the Company
agreed with BSB to pay down approximately $250,000 of the collateralized line of
credit, representing the amount in excess of the borrowing base.  Such excess
amount had been cash collateralized.   In connection with such agreement, the
line of credit will be extended to March 31, 2001.  In addition, the Company
agreed to issue BSB warrants to purchase 50,000 shares of the Company's common
stock at an exercise price of $1.00 per share.

In conjunction with the Securities Purchase Agreement, on February 16, 1999,
the Company issued to BSB, a five year warrant to purchase an aggregate of
500,000 shares of the Company's common stock at an exercise price of $0.575 per
share (the "BSB Warrant").  The shares issuable upon exercise of the BSB Warrant
contain certain registration rights. The value of the BSB warrant has been
reflected as deferred financing costs in the Company's financial statements and
will be amortized over the period commencing from date of issue to May 31, 2000.

On March 14, 2000, the Company entered into a Waiver and Lock-up Agreement with
BSB, pursuant to which BSB waived any rights to adjustment that it may have
under the BSB Warrant. In addition, BSB agreed not to transfer the shares of
Common Stock issuable to BSB upon conversion of the BSB Warrant until March 20,
2001 without the prior written consent of the Company.  The Series B Convertible
Preferred Stock and warrants purchased by bmp (and subsequently transferred to
ANB) contain certain provisions relating to antidilution protection against
private placement issuances of securities below fair market value.  The Company
has had certain discussions with a representative of ANB concerning the
applicability of these provisions to the private placements consummated
subsequent to January 1, 2000.  The Company has contended that no such
adjustment is required and sought a waiver of such provisions.  To date, no
agreement has been reached.  To the extent it is determined that such adjustment
is required, the failure to reach such agreement could result in an increase in
the number of shares of the Company's common stock issuable upon exercise of the
Series B Convertible Preferred Stock and warrants and thereby result in
potential dilution to existing shareholders.

In September 1999, 2,979,256 shares of Common Stock were issued in a private
placement at an aggregate purchase price of $1,117,221.  The Company received
$1,061,422 net of finder's fees. The shares of Common Stock issued in this
private placement contain certain piggyback registration rights.

The Company has issued an  aggregate of  12,833,333  shares of Common Stock
and 9,743,333  warrants in a series of private  placements  consummated  between
December  31, 1999 and March 31, 2000.  The Company  raised an aggregate of
$5,730,000  from such private  placements at purchase prices ranging between
$0.30 and $0.50 per share and warrant exercise prices ranging  between $0.75 and
$1.0625 per share.  The warrants range between 4 to 5 year warrants.  The
Company is in discussions with certain other  investors  concerning  up to an
additional $4 million of private placement equity financing.  There can be no
assurance that such additional financing can be consummated.

<PAGE>
                                       9

Item 2.  Managements Discussion and Analysis or Plan of Operation

Certain statements in this Report under the caption "Managements'
Discussion and Analysis or Plan of Operation" and elsewhere constitute or may
constitute "forward-looking" statements within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Litigation Reform Act"),
including, without limitation, statements regarding future cash requirements.
The Company desires to avail itself of certain "safe harbor" provisions of the
Litigation Reform Act and is therefore including this special note to enable
the Company to do so. Such forward-looking statements involve known and unknown
risks, uncertainties and other factors which may cause the actual results,
performance or achievements of the Company, or industry results, to be
materially different from any future results, performance, or achievements
expressed or implied by such forward-looking statements. Such factors include,
among others, the following: inability to obtain additional financing on
acceptable terms, manufacturing delays due to equipment or technical problems,
delays in product development; inability to expand into telecommunications
products; costs associated with and outcome of investigations described
elsewhere herein; failure to receive or delays in receiving regulatory approval;
lack of enforceability of patents and proprietary rights; general economic and
business conditions; industry capacity; industry trends;demographic changes;
competition; material costs and availability; the loss of any significant
customers; changes in business strategy or development plans;quality of
management; availability, terms and deployment of capital; business abilities
and judgment of personnel; availability of qualified personnel; changes in, or
the failure to comply with, government regulations; and other factors referenced
in this report.

Overview

The Company was considered a development stage company until April 1, 1997.
During 1997, the Company began the commercialization of many of its
proposed products.  Since its inception in 1993, the Company had been
engaged primarily in research and development, business and financial
planning, recruitment of key management and technical personnel, raising
capital to fund operations and the development of its HPDL product
prototypes.  The Company has since completed the construction and equipping of
the first phase of its manufacturing facility and has begun the
commercialization of its products and the generation of sales revenues.  The
Company is seeking to increase sales in order to fully utilize its production
capacity. Increasing sales levels and higher utilization of production capacity
are critical to the Company's financial success.  Financial resources and
liquidity during this period of growth are of utmost importance and concern to
the Company.

The Company has raised an aggregate of $5,730,000  from a series of private
placements  since January 1, 2000. The Company is currently in discussions  with
investors  regarding an  additional  financing of up to $4 million.  The Company
intends to grow its business through expansion into telecommunications products.
The Company has the capability without  substantial  capital  expenditures or an
expansion of staff to manufacture products with telecommunications applications.
If the Company is successful in raising  additional  financing it is anticipated
that it will expend between $500,000 to $4,000,000 on capital expenditures  to
expand significantly the products with telecommunications applications that the
Company could  manufacture.  Therefore,  with  additional equity financing the
Company believes that the potential for revenues in the area of
telecommunications is significantly increased.  However, there can be no
assurances that additional equity financing can be obtained, or that the Company
can increase sales in telecommunications.

The manufacture of semiconductor lasers such as those sold by the Company is
a highly complex and precise process, requiring production in a highly
controlled and clean environment with the utilization of materials free of
defects and contamination.  These factors have a significant impact on
production yields and product reliability which in turn affect operating
results and future customer acceptance.  The Company as well as other
semiconductor laser manufacturers have, from time to time, experienced
technical production problems which have resulted in adverse financial
consequences.  No assurance can be given that the Company's systems,
procedures, procurement efforts and production process are such that these
problems will not be experienced in the future.

Since the onset of commercial production, the Company, on occasion, has
been unable to manufacture certain products in quantities sufficient to meet
the demands of its existing customer base and that of new customers based upon
equipment and/or other technical problems arising at various points during the
production process.  At this time the Company is not experiencing any technical
difficulty of its production processing.  Historically, cash flow problems have
placed considerable strain on Company management, financial, manufacturing and
other resources and limited the Company's ability to grow its revenues.
Although the Company has raised $5,730,000 in private placement financing since
January 1, 2000, lack of financial resources in the future could have a material
adverse impact on the Company's business and results of operations.

The Company has not generated material revenues or profits to date.


<PAGE>
                                       10


Results of Operations

Sales for the three months ended March 31, 2000 were $405,850, representing
an increase of 36% over the first three months ended March 31, 1999.  Although
government sales decreased, commercial sales increased in the comparison period.

The Company has a purchase order with a customer in China for approximately
$4 million for a single chip high power  diode.  Such  customer  has held up the
shipment  of  approximately  $140,000 in products  already  manufactured  by the
Company and delayed  processing of the next production order pending  resolution
of a claim by an  agent in China  claiming  to have an  exclusive  sales  agency
relationship  with the Company and  therefore to be entitled to a commission  on
the orders  with this  customer.  The Company  believes  that the claims of this
agent are completely without merit and has terminated its relationship with this
agent.  There can be no assurance  that the customer will be satisfied  with the
resolution  of this claim or  willing  to permit  shipments  and  production  to
resume.  As a result,  revenues  anticipated to received in the second and third
quarters will be delayed and, if the dispute as to this agent's rights cannot be
resolved to the  satisfaction  of the customer,  the Company may not realize any
additional  revenues from this  customer.  Even if the dispute is resolved,  the
realization  of the  full $4  million  amount  of the  order is  subject  to the
Company's ability to satisfy the customer on quality and quantity  requirements.
If the dispute is resolved,  and the Company can satisfy the customer on quality
and quantity requirements, the order size may be increased.

Cost of sales, which includes materials, production labor and equipment costs
increased 22.5% to $813,766 for the three months ended March 31, 2000 as
compared to $663,886 for the three months ended March 31, 1999.  Gross margin
declined as a result of the increase in the cost of sales.  Cost of sales levels
are expected to exceed sales levels until the volume of sales increases.  The
Company expects sales levels to increase in the future, thus steadily increasing
production levels to levels approaching optimum capacity, although no such
assurance can be provided.

<PAGE>
                                       11

Research and Development("R & D") expenditures were $11,774 for the three months
ended March 31, 2000 as compared to $1,738 in the same period in 1999.  The
increase in such expenditures is primarily associated with the majority of R & D
expenses in the first quarter of 1999 being charged to the cost of sales for
such quarter.

Sales and Marketing expenses were $82,681 for the three months ended March 31,
2000 as compared to $63,220 for the same period in 1999.  The increase is
attributable to increases in costs associated with trade show expenses
partially offset by a decrease in advertising expenses.

General and Administrative expenses were $821,861 for the three months ended
March 31, 2000 as compared to $570,804 for the same period in 1999. Such
increase was primarily attributable to an increase in professional fees of
$184,227, insurance costs of $14,266 and loan interest expense of $32,431.
Additionally, hourly wages increased net of salary decreases from the first
quarter of 1999 compared to the first quarter of 2000 by $27,833.  Increases
amounting to $19,632 were experienced in other miscellaneous expenses.
Offsetting these increases were decreases in maintenance expenses of $18,028 due
to less frequent repairs and a decrease in outside services expense of $9,304
due to reduced requirements.

Interest income increased $20,160 as a result of higher levels of invested cash
in the first quarter of 2000 compared to the same period in 1999.

Liquidity and Capital Resources

The Company's cash and cash equivalents at March 31, 2000 were $4,999,660 as
compared to $347,747 at December 31, 1999, a net increase of $4,651,913 for the
three months ended March 31, 2000.  The increase is the result of $1,167,539
used in operating activities and $5,819,452 provided by financing activities.

The $5,819,454 provided by financing activities was derived from the issuance
of 12,833,333 shares of common stock and warrants to purchase 9,743,333 shares
of Common Stock for an aggregate gross consideration of $5,830,000.  The former
was offset by payments on the long-term debt.

The Company has available a collateralized line of credit with BSB Bank(the
"Loan Agreement"), subject to a borrowing base calculation, with an aggregate
availability in the amount of $1,000,000 for purposes of providing working
capital. The line, bears interest at prime plus 2.5%. The Company has utilized
$1,000,000 of this line as of March 31, 2000.

In January 2000, BSB required the Company to provide it with additional security
for the Loan Agreement in the form of a $750,000 second mortgage on the
Company's facility and a first security interest in all of its assets.  The
second mortgage and the security agreement granting the requested security
interest were executed and delivered to BSB on January 31, 2000.  BSB has agreed
to release the lien of the second mortgage upon satisfaction of its first
mortgage, and a pay down or permanent reduction of the Company's line of credit
with BSB of $300,000 or a pledge of cash collateral in such amount.

BSB agreed to waive the default of the Company under the Loan Agreement with
respect to "Mandatory Loan Repayments" and waived the Affirmative Covenants -
"Financial Covenants and Ratios" at December 31, 1999. Subsequently, BSB agreed
to waive the default of the Company under the Loan Agreement with respect to
"Mandatory  Loan  Repayments" for the period ending February 29,
2000 provided the Company met the  borrowing  base  requirements  as of March 3,
2000. These requirements were met by the Company.  On May 8, 2000, the Company
agreed with BSB to pay down approximately $250,000 of the collateralized line of
credit, representing the amount in excess of the borrowing base.  Such excess
amount had been cash collateralized.   In connection with such agreement, the
line of credit will be extended to March 31, 2001.  In addition, the Company
agreed to issue BSB warrants to purchase 50,000 shares of the Company's common
stock at an exercise price of $1.00 per share.


<PAGE>
                                       12

The Company entered into a Securities  Purchase  Agreement (the "Securities
Purchase Agreement"), dated as of February 5, 1999, with bmp Mobility AG Venture
Capital ("bmp"),  as amended by Amendment No. 1 to Securities Purchase Agreement
(the  "Amendment"),  dated  as  of  April  28,  1999  (the  Securities  Purchase
Agreement,  as  amended  by the  Amendment  is  hereinafter  referred  to as the
"Amended  Purchase  Agreement").  Pursuant to the terms of the Amended  Purchase
Agreement, bmp purchased, 2,000,000 shares of the Company's Common Stock and
1,000,000  shares of the Company's Series B Convertible  Preferred Stock ,$.01
par value per share (the "Series B Stock"),  each  convertible  into 5 shares
of the  Company's  Common  Stock or an aggregate of 5,000,000 shares of the
Company's Common Stock.  bmp had  previously  purchased  367,650  shares  of the
Company's  Common Stock in  unrelated  open market  transactions.  In connection
with the Amendment, on June 26, 1999 the Company issued to bmp a five year
warrant to purchase an aggregate of 500,000 shares Common Stock, at an exercise
price of $0.50 per share (the "bmp Warrrant").  The shares of Common Stock
issued to bmp contain certain demand and piggyback registration rights and the
Series B Stock contains certain anti-dilution rights.Based on public filings,
the Company is aware that bmp has transferred ownership of its shares of Common
Stock, Series B Stock and the bmp Warrant to ANB Alster Neue Beiteiligungs GmbH
KG ("ANB").

      In September 1999, 2,979,256  shares of Common Stock were issued at an
aggregate  purchase price of $1,117,221.  The Company received $1,061,422  net
of  finder's  fees.  The shares of Common  Stock  issued in this private
placement contain certain piggyback registration rights.

     The Company has issued an  aggregate of  12,833,333  shares of Common Stock
and 9,743,333  warrants in a series of private  placements  consummated  between
December  31, 1999 and March 31, 2000.  The Company  raised an  aggregate of
$5,730,000 in gross proceeds from such private placements  at purchase  prices
ranging between $0.30 and $0.50 per share and warrant  exercise  prices  ranging
between $0.75 and  $1.0625  per share.  The warrants range between 4 to 5 year
warrants.  On March 14, 2000, the Company entered into a Waiver and Lock-up
Agreement with BSB, pursuant to which BSB waived any rights to adjustment that
it may have under the BSB  Warrant.  In addition, BSB agreed not to transfer the
shares of Common Stock issuable to BSB upon  conversion of the BSB Warrant until
March 20, 2001 without the prior  written  consent of the  Company.  The Series
B Convertible Preferred Stock and warrants purchased by bmp (and subsequently
transferred to ANB) contain certain provisions relating to antidilution
protection against private placement issuances of securities below fair market
value.  The Company has had certain discussions with a representative of ANB
concerning the applicability of these provisions to the private placements
consummated subsequent to January 1, 2000.  The Company has contended that no
such adjustment is required and sought a waiver of such provisions.  To date, no
agreement has been reached.  To the extent it is determined that such adjustment
is required, the failure to reach such agreement could result in an increase in
the number of shares of the Company's common stock issuable upon exercise of the
Series B Convertible Preferred Stock and warrants and thereby result in
potential dilution to existing shareholders.

     The Company has filed a registration statement with the Securities and
Exchange Commission to register certain shares issued in private placements
consummated over the preceding 12 months.

     The Company has incurred net losses from inception and has an accumulated
deficit at March 31, 2000 of $21,632,794.  These losses have been financed
primarily out of proceeds from the Company's initial public offering and private
equity financings. The Company expects that its cash and working capital
requirements will continue to be significant as its operations expand.
Potential sources for such cash and working capital requirements are
revenue growth and additional private equity financing. It is anticipated that
the Company will continue to incur losses for the immediate future until it is
able to achieve profitable operations or to generate sales sufficient to support
its operations.

     The Company is in discussions with certain other investors concerning up to
an additional $4 million of private placement financing.  There can be no
assurance that such additional  financing can be consummated. The need to raise
equity capital at current stock prices is likely to result in substantial
dilution to shareholders and could result in a change of control.  One investor
who purchased shares and warrants in March 2000, now beneficially owns 53.4% of
the common stock, inclusive of warrants purchased by such investor.

  The Company anticipates that capital expenditures during fiscal 2000 will
range between approximately $500,000 and $4,000,000 depending on the level of
additional financing raised.

     There can be no assurance that the Company will be able to obtain
additional financing, including any institutional financing, when needed, on
commercially reasonable terms or at all.  Therefore, it is uncertain that the
Company will be able to meet its obligations as they become due.


<PAGE>
                                       13


                          PART II. - OTHER INFORMATION

Item 1. Legal Proceedings.

     The Company is involved in litigation described in Note 5 in the
     financial statements.


Item 2. Changes in Securities and Use of Proceeds.

     None


Item 3. Defaults Upon Senior Securities.

     None


Item 4. Submission of Matters to a Vote of Security Holders.

     None


Item 5. Other Information.

Roger D. O'Brien, who served as a director of the Company during fiscal 1999,
advised the Company of his resignation as a director of the Company, effective
as of February 29, 2000.  There has been no disagreement between the Company and
Mr. O'Brien.

Item 6. Exhibits and Reports on Form 8-K.

         (a)   Exhibits.

              27   Financial Data Schedule

         (b)   Reports on Form 8-K.

                     None

<PAGE>
                                         14

                                 SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned,  thereunto duly
authorized.


                    Semiconductor Laser International Corporation
                    ---------------------------------------------
                                     (Registrant)



Date: May 15, 2000                   By:/s/ Geoffrey T Burnham
                                        ----------------------------
                                        Geoffrey T. Burnham
                                          Chairman of the Board, President
                                          and Chief Executive Officer
                                          (principal executive officer)

Date: May 15, 2000                   By:/s/ Leonard E. Lundberg
                                        ----------------------------
                                        Leonard E. Lundberg
                                          Chief Financial Officer,
                                          Principal Financial Officer
                                          and Principal Accounting Officer


<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1

<S>                        <C>
<PERIOD-TYPE>              3-MOS
<FISCAL-YEAR-END>                         DEC-31-2000
<PERIOD-START>                            JAN-01-2000
<PERIOD-END>                              MAR-31-2000
<CASH>                                      4,999,660
<SECURITIES>                                        0
<RECEIVABLES>                                 873,976
<ALLOWANCES>                                  583,293
<INVENTORY>                                   877,074
<CURRENT-ASSETS>                            6,190,749
<PP&E>                                      3,210,600
<DEPRECIATION>                                677,076
<TOTAL-ASSETS>                              8,858,700
<CURRENT-LIABILITIES>                       2,008,963
<BONDS>                                             0
                               0
                                    10,000
<COMMON>                                      284,744
<OTHER-SE>                                  5,751,871
<TOTAL-LIABILITY-AND-EQUITY>                8,858,700
<SALES>                                       405,850
<TOTAL-REVENUES>                              405,850
<CGS>                                         813,766
<TOTAL-COSTS>                                 813,766
<OTHER-EXPENSES>                              847,820
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                             68,496
<INCOME-PRETAX>                            (1,303,767)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                        (1,303,767)
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                               (1,303,767)
<EPS-BASIC>                                    (.07)
<EPS-DILUTED>                                    (.07)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission